Search Drug Information, Interactions, Images, Dosage & Side Effects

PPI prophylaxis may protect against post-PVI mediastinal complications 08 Mar 2021
Prophylaxis with proton pump inhibitors (PPI) can potentially avert mediastinal lesions associated with pulmonary vein isolation (PVI) among atrial fibrillation patients with pre-existing reflux oesophagitis, a recent study has shown.

COVID-19 after-effects evident 3 months after hospital discharge

08 Mar 2021

Sidewalks may curb dementia risk in urban areas

08 Mar 2021

Severe mitroaortic valve dysfunction prevalent in systemic sclerosis

08 Mar 2021

Novel tool predicts progression to severe disease, death in COVID-19 patients

08 Mar 2021

IR sensitivity lower, β cell function higher in RA vs SLE patients

08 Mar 2021

Physical activity, sedentary time vital for weight management in diabetics

08 Mar 2021

Long-term contact lens use safe in kids

08 Mar 2021

Intensive lipid-lowering therapy benefits patients with polyvascular disease, too

08 Mar 2021

GWAS meta-analysis finds over forty new risk loci for POAG

07 Mar 2021

One-week doxycycline outshines single-dose azithromycin for rectal chlamydia

07 Mar 2021

A Guide on Primary Immunodeficiency Disease and Allergies 05 Feb 2021;

Primary immunodeficiency disease (PIDD) and allergies are two groups of conditions related to the immune system. However, they are uniquely different in terms of symptoms and treatment.

Optimizing metastatic hormone-sensitive prostate cancer treatment in advanced prostate cancer

Assoc Prof. Darren Poon, Assoc Prof. Edmund Chiong, 14 Jan 2021

ALL treatment: Current settings, future goals

Roshini Claire Anthony, 08 Jan 2021

Spotlight on multidrug-resistant gram-negative infections: New developments for an old problem

Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021

Trezilent

Contents : Alpelisib

Indications/Uses : In combination w/ fulvestrant for postmenopausal women & men w/ hormone-receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer following progression on or after endocrine-based regimen.

Vizimpro

Contents : Dacomitinib

Indications/Uses : 1st-line treatment of patients w/ metastatic non-small cell lung cancer (NSCLC) w/ epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutations.

Adacel

Contents : Per 0.5 mL Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, pertactin 3 mcg, fimbriae types 2 & 3 5 mcg

Indications/Uses : Active booster immunization for prevention of tetanus, diphtheria & pertussis (whooping cough) in persons ≥4 yr. Passive protection against pertussis in early infancy following maternal immunization during pregnancy. Concomitant w/ inactivated poliomyelitis vaccine as alternative for 5th dose of tetanus, diphtheria & acellular pertussis vaccine (DTaP) in childn 4-6 yr.

New Molecule

3 New

New Indication

5 New

New Brand

2 New

pill identifier

Shape

Form

Color 1

Color 2

Markings

Shape

Form

Color 1

Color 2

Search Drug Information, Images & Medical News | MIMS Malaysia

Trezilent

Vizimpro

Adacel